Patient Factors But Not the Use of Novel Anticoagulants or Warfarin Are Associated With Internal Jugular Vein Access-Site Hematoma After Right Heart Catheterization.
CONCLUSION: The incidence of internal jugular vein access-site hematoma is small when using careful access techniques for RHC even with the continued use of novel oral anticoagulants and warfarin. Patient characteristics and co-morbid conditions are related to bleeding complications.
PMID: 29207361 [PubMed - in process]
Source: The Journal of Invasive Cardiology - Category: Cardiology Tags: J Invasive Cardiol Source Type: research
More News: Bleeding | Cardiac Catheterization | Cardiology | Coumadin | Databases & Libraries | Dialysis | Heart | Laboratory Medicine | Statistics | Ultrasound | Warfarin